GovChime
Notice ID: 3dae5ab4c30f4fbd88a6d4eb53c41b0bAward NoticeAwarded

6505--Semaglutide (Ozempic) Inj Soln - GLP1A Glucagon-like Peptide 1 Receptor Agonists

Awarded on September 22, 2020. Full description on SAM.gov.

Awarded tounder 36E79720D0071 (source: SAM.gov award notice)• $598.2M

Overview

Posted
September 22, 2020
Notice type
Award Notice
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of Veterans Affairs

Notice details

Last updated
Apr 29, 2026
Award date
Sep 22, 2020
Award amount (SAM.gov award notice)
$598.2M

Identifiers

Solicitation number
36E79720R0055
Notice ID
3dae5ab4c30f4fbd88a6d4eb53c41b0b
Award number (PIID)
36E79720D0071

Description

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0055 for an unrestrictive procurement for once-weekly Glucagon-like peptide-1 receptor agonists (GLP1 agonist) with an FDA approved indication to reduce risk of major cardiovascular outcomes in adults with type 2 diabetes for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA Pharmaceutical Prime Vendor Program. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79720R0055 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about June 17, 2020, with a tentative closing date of July 2, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Teresa Hussain. Questions can be e-mailed to: Teresa.Hussain@va.gov. The estimated annual requirements are as follows: Item Description Size Estimated Annual Requirements 1a DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN 4 PACK OR 1 383,700 1b SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML 1 PACK AND 2a DULAGLUTIDE 1.5MG/0.5ML INJ,SOLN,PEN 4 PACK OR 1 536,592 2b SEMAGLUTIDE 1MG/0.75ML INJ,SOLN,PEN,1.5ML 2 PACK

Full description on SAM.gov

Award Overview

Award Number

36E79720D0071

Award Amount (SAM.gov award notice)

$598.2M

Award Date

Sep 22, 2020

Awardee

Awardee UEI

W72BJMJYBMN3

Original Solicitation

Notice ID: 3dae5ab4c30f4fbd88a6d4eb53c41b0b

Posted Date: Sep 22, 2020

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

5
  • 36F79719D0181
    NOVO NORDISK INC.
    Department of Veterans AffairsNAICS 325412
    —Signed Nov 5, 2026
  • 36F79719D0181
    NOVO NORDISK INC.
    Department of Veterans AffairsNAICS 325412
    —Signed Sep 22, 2026
  • 36F79719D0181
    NOVO NORDISK INC.
    Department of Veterans AffairsNAICS 325412
    —Signed Sep 1, 2026
  • 36F79719D0181
    NOVO NORDISK INC.
    Department of Veterans AffairsNAICS 325412
    —Signed Aug 24, 2026
  • 36F79719D0181
    NOVO NORDISK INC.
    Department of Veterans AffairsNAICS 325412
    —Signed Aug 24, 2026

Contacts

Documents

No documents available.

Lifecycle

Solicitation:36E79720R0055
  1. Pre-Solicitation
  2. Solicitation
  3. Awarded

This opportunity has been awarded.

  1. Pre-SolicitationJun 4, 2020

    6505--GLP1A Glucagon-like Peptide 1 Receptor Agonists

    Notice 5c6746573f0c490997f44b9ac2e45a41 on SAM.gov

  2. 3×
    SolicitationJun 26, 2020

    6505--GLP1A Glucagon-like Peptide 1 Receptor Agonists

    Notice c8b2ae78500b4f82bf355ebd39adb493 on SAM.gov

  3. AwardedCurrentSep 22, 2020

    6505--Semaglutide (Ozempic) Inj Soln - GLP1A Glucagon-like Peptide 1 Receptor Agonists

    Notice 3dae5ab4c30f4fbd88a6d4eb53c41b0b on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

36E79720R0055

Archive Date

Nov 21, 2020

Office Address

HINES, IL, 60141